DCTH Quote, Financials, Valuation and Earnings

Exact Sciences has a net margin of -22.5% compared to Delcath Systems's net margin of -121.19%. Delcath Systems's return on equity of -117.89% beat Exact Sciences's return on equity of -34.11%.

Delcath Systems has a consensus price target of $22.50, signalling upside risk potential of 79%. On the other hand Exact Sciences has an analysts' consensus of $68.89 which suggests that it could grow by 58.55%. Given that Delcath Systems has higher upside potential than Exact Sciences, analysts believe Delcath Systems is more attractive than Exact Sciences.

Delcath Systems has a beta of 0.853, which suggesting that the stock is 14.729% less volatile than S&P 500. In comparison Exact Sciences has a beta of 1.136, suggesting its more volatile than the S&P 500 by 13.608%.

Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

Delcath Systems quarterly revenues are $15.1M, which are smaller than Exact Sciences quarterly revenues of $713.4M. Delcath Systems's net income of -$3.4M is higher than Exact Sciences's net income of -$864.6M. Notably, Delcath Systems's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 9.94x versus 2.90x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of -22.5% compared to Delcath Systems's net margin of 16.94%. Delcath Systems's return on equity of -117.89% beat Illumina's return on equity of -35.09%.

Delcath Systems has a consensus price target of $22.50, signalling upside risk potential of 79%. On the other hand Illumina has an analysts' consensus of $130.64 which suggests that it could grow by 66.66%. Given that Delcath Systems has higher upside potential than Illumina, analysts believe Delcath Systems is more attractive than Illumina.

Delcath Systems has a beta of 0.853, which suggesting that the stock is 14.729% less volatile than S&P 500. In comparison Illumina has a beta of 1.376, suggesting its more volatile than the S&P 500 by 37.551%.

Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend.

Delcath Systems quarterly revenues are $15.1M, which are smaller than Illumina quarterly revenues of $1.1B. Delcath Systems's net income of -$3.4M is lower than Illumina's net income of $187M. Notably, Delcath Systems's price-to-earnings ratio is -- while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 9.94x versus 2.86x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Neuronetics has a net margin of -22.5% compared to Delcath Systems's net margin of -56.29%. Delcath Systems's return on equity of -117.89% beat Neuronetics's return on equity of -178.53%.

Delcath Systems has a consensus price target of $22.50, signalling upside risk potential of 79%. On the other hand Neuronetics has an analysts' consensus of $6.83 which suggests that it could grow by 80.78%. Given that Neuronetics has higher upside potential than Delcath Systems, analysts believe Neuronetics is more attractive than Delcath Systems.

Delcath Systems has a beta of 0.853, which suggesting that the stock is 14.729% less volatile than S&P 500. In comparison Neuronetics has a beta of 1.975, suggesting its more volatile than the S&P 500 by 97.503%.

Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Neuronetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Neuronetics pays out -- of its earnings as a dividend.

Delcath Systems quarterly revenues are $15.1M, which are smaller than Neuronetics quarterly revenues of $22.5M. Delcath Systems's net income of -$3.4M is higher than Neuronetics's net income of -$12.7M. Notably, Delcath Systems's price-to-earnings ratio is -- while Neuronetics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 9.94x versus 1.60x for Neuronetics. Usually stocks with elevated PS ratios are considered overvalued.

Star Equity Holdings has a net margin of -22.5% compared to Delcath Systems's net margin of -14.37%. Delcath Systems's return on equity of -117.89% beat Star Equity Holdings's return on equity of -17.45%.

Delcath Systems has a consensus price target of $22.50, signalling upside risk potential of 79%. On the other hand Star Equity Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 323.73%. Given that Star Equity Holdings has higher upside potential than Delcath Systems, analysts believe Star Equity Holdings is more attractive than Delcath Systems.

Delcath Systems has a beta of 0.853, which suggesting that the stock is 14.729% less volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.205%.

Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

Delcath Systems quarterly revenues are $15.1M, which are smaller than Star Equity Holdings quarterly revenues of $17.1M. Delcath Systems's net income of -$3.4M is lower than Star Equity Holdings's net income of -$2.5M. Notably, Delcath Systems's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 9.94x versus 0.14x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.